Short Interest in CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) Increases By 239,997.9%

CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) saw a large increase in short interest during the month of December. As of December 15th, there was short interest totaling 1,939,991 shares, an increase of 239,997.9% from the November 30th total of 808 shares. Based on an average trading volume of 30,134,177 shares, the days-to-cover ratio is currently 0.1 days. Based on an average trading volume of 30,134,177 shares, the days-to-cover ratio is currently 0.1 days.

CNBX Pharmaceuticals Stock Performance

Shares of CNBX Pharmaceuticals stock remained flat at $0.00 during trading on Wednesday. The stock had a trading volume of 6,954,035 shares, compared to its average volume of 13,486,065. CNBX Pharmaceuticals has a 12-month low of $0.00 and a 12-month high of $0.02.

CNBX Pharmaceuticals Company Profile

CNBX Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the research and development of synthetic cannabinoid-based drug candidates. The company’s proprietary platform applies medicinal chemistry techniques to design novel small-molecule analogs of naturally occurring cannabinoids, aiming to improve efficacy and safety compared with existing therapies. Its pipeline includes multiple preclinical compounds targeting neuropathic and chronic pain, with a goal of advancing these candidates through IND-enabling studies.

Headquartered in Costa Mesa, California, CNBX Pharmaceuticals collaborates with contract research organizations and academic partners to conduct pharmacology and toxicology studies as well as scale up manufacturing processes.